Phase 4 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Rheumatoid Arthritis (RA) using recognised medical guidelines, AND you have problems with your knee function.
- You meet the 1987 RA classification by having at least 4 of these 7 signs: morning stiffness lasting at least 1 hour (for 6+ weeks); 3 or more swollen joint areas (for 6+ weeks); swelling in the wrist or finger joints (for 6+ weeks); matching swelling on both sides of the body (for 6+ weeks); specific hand X-ray changes; or a positive rheumatoid factor blood test (confirm with trial site).
- Alternatively, you may qualify under 2010 RA guidelines, which use a scoring system based on which joints are affected, certain blood test results, inflammation markers, and how long symptoms have lasted (confirm with trial site).
- OR you have been diagnosed with Osteoarthritis (OA) of the knee, with most-days knee pain in the last month, plus other specific signs such as a grating sound in the knee, morning stiffness lasting 30 minutes or less, being aged 38 or older, or bony enlargement around the knee.
- OR you are a healthy volunteer of a similar age and sex to the patients, who has had a check-up at the hospital involved in the trial.
- You are over 18 years old.
- You are willing to take part and are able to sign a consent form.
Who may not be able to join:
- People who currently have active hepatitis (a liver infection).
- People who currently have active tuberculosis (TB).
- People who currently have an active infection of any kind, or who have been diagnosed with cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaoyun Yang, Qilu Hospital of Shandong University
Phone: 0086-0531-82169654
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The percentage of patients who achieve clinical remission using European League Against Rheumatism (EULAR) response criteria DAS28.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.